Insider Transactions in Q1 2021 at Biohaven Pharmaceutical Holding CO Ltd. (BHVN)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2021
|
John W Childs |
BUY
Open market or private purchase
|
Direct |
13,157
+0.51%
|
$999,932
$76.0 P/Share
|
|
Mar 02
2021
|
John W Childs |
BUY
Open market or private purchase
|
Direct |
10,000
+0.39%
|
$850,000
$85.14 P/Share
|
|
Jan 25
2021
|
John W Childs |
BUY
Other acquisition or disposition
|
Direct |
5,706
+0.23%
|
-
|
|
Jan 06
2021
|
Vlad Coric Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,802
-23.01%
|
$481,566
$83.38 P/Share
|
|
Jan 06
2021
|
Vlad Coric Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+33.15%
|
-
|
|
Jan 06
2021
|
Charles Conway Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,747
-14.86%
|
$145,001
$83.38 P/Share
|
|
Jan 06
2021
|
Charles Conway Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+24.18%
|
-
|
|
Jan 06
2021
|
James Engelhart Strategic Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
1,747
-15.94%
|
$145,001
$83.38 P/Share
|
|
Jan 06
2021
|
James Engelhart Strategic Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+25.5%
|
-
|
|
Jan 06
2021
|
Kimberly Gentile SVP, Clinical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,747
-18.51%
|
$145,001
$83.38 P/Share
|
|
Jan 06
2021
|
Kimberly Gentile SVP, Clinical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+28.43%
|
-
|
|
Jan 06
2021
|
Elyse Stock Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,250
+36.37%
|
-
|
|
Jan 06
2021
|
Elyse Stock Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,747
-23.49%
|
$145,001
$83.38 P/Share
|
|
Jan 06
2021
|
Elyse Stock Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+33.52%
|
-
|
|
Jan 06
2021
|
William A Jones Jr CCO-Migraine & Common Disease |
SELL
Payment of exercise price or tax liability
|
Direct |
2,124
-22.96%
|
$176,292
$83.38 P/Share
|
|
Jan 06
2021
|
William A Jones Jr CCO-Migraine & Common Disease |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+35.09%
|
-
|
|
Jan 06
2021
|
John Tilton Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-15.61%
|
$40,836
$83.38 P/Share
|
|
Jan 06
2021
|
John Tilton Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+28.4%
|
-
|